ES2141095T3 - Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso. - Google Patents
Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso.Info
- Publication number
- ES2141095T3 ES2141095T3 ES92115878T ES92115878T ES2141095T3 ES 2141095 T3 ES2141095 T3 ES 2141095T3 ES 92115878 T ES92115878 T ES 92115878T ES 92115878 T ES92115878 T ES 92115878T ES 2141095 T3 ES2141095 T3 ES 2141095T3
- Authority
- ES
- Spain
- Prior art keywords
- monoclonal antibodies
- tumors
- procedure
- preparation
- antibodies against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 208000009956 adenocarcinoma Diseases 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3038—Kidney, bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
LA PRESENTE INVENCION CONCIERNE A ANTICUERPOS MONOCLONALES, CONTRA UN ANTIGENO ASOCIADO A UN TUMOR, A UN TUMOR DE ORIGEN PREFERENTEMENTE DEL GRUPO DE CARCINOMAS DE MAMA, OVARIO, PROSTATA ASI COMO ADENOCARCINOMAS DE PULMON, QUE REACCIONAN ADICIONALMENTE CON LA "MUCINA POLIMORFICA EPITELIAL" (PEM), SU OBTENCION Y UTILIZACION, ASI COMO LA UTILIZACION DE LOS EPITOPES DEFINIDOS POR LOS ANTICUERPOS, PARA EL DIAGNOSTICO Y TERAPIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4133791A DE4133791A1 (de) | 1991-10-11 | 1991-10-11 | Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2141095T3 true ES2141095T3 (es) | 2000-03-16 |
Family
ID=6442537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92115878T Expired - Lifetime ES2141095T3 (es) | 1991-10-11 | 1992-09-17 | Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso. |
Country Status (11)
Country | Link |
---|---|
US (4) | US5837824A (es) |
EP (1) | EP0537489B1 (es) |
JP (1) | JP3996649B2 (es) |
AT (1) | ATE187463T1 (es) |
AU (1) | AU670247B2 (es) |
CA (1) | CA2080260C (es) |
DE (2) | DE4133791A1 (es) |
ES (1) | ES2141095T3 (es) |
FI (1) | FI924543A (es) |
NZ (1) | NZ244661A (es) |
ZA (1) | ZA927785B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2118010C (en) * | 1992-04-13 | 2003-10-28 | Donald Kufe | Antibodies specific for carcinoma-associated antigens |
US6030797A (en) * | 1992-10-08 | 2000-02-29 | Dade Behring Marburg Gmbh | Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof |
US6207805B1 (en) | 1997-07-18 | 2001-03-27 | University Of Iowa Research Foundation | Prostate cell surface antigen-specific antibodies |
DE69942742D1 (de) * | 1998-06-15 | 2010-10-21 | Quest Pharmatech Inc | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs |
JP5007409B2 (ja) * | 2000-05-08 | 2012-08-22 | セルデックス リサーチ コーポレーション | 樹状細胞に対するヒトモノクローナル抗体 |
US6949629B2 (en) * | 2002-03-13 | 2005-09-27 | Aspenbio, Inc. | Methods for purifying selected CEA family member proteins |
WO2007081779A2 (en) * | 2006-01-05 | 2007-07-19 | Genentech, Inc. | Methods of determining cutoff points |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5640033A (en) * | 1979-09-07 | 1981-04-16 | Fujitsu Ltd | Cold water type cooling system utilizing open air for cooling water |
DE3329184A1 (de) * | 1983-08-12 | 1985-02-21 | Behringwerke Ag, 3550 Marburg | Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene |
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
ATE143052T1 (de) * | 1986-07-07 | 1996-10-15 | Centocor Inc | Chimärisches murine-mensch-immunoglobulin, spezifisch für tumorassoziertes 17-1a antigen |
DE3825615A1 (de) * | 1988-07-28 | 1990-02-01 | Behringwerke Ag | Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung |
US5185254A (en) * | 1988-12-29 | 1993-02-09 | The Wistar Institute | Gene family of tumor-associated antigens |
DE3909799A1 (de) * | 1989-03-24 | 1990-09-27 | Behringwerke Ag | Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung |
EP0397419A3 (en) * | 1989-05-10 | 1991-04-03 | Hybritech Incorporated | Novel tumor-associated antigen, antibodies, compositions and uses therefor |
WO1991002079A1 (en) * | 1989-07-31 | 1991-02-21 | The University Of British Columbia | Monoclonal antibodies against a tumor-associated antigen |
DE4005630A1 (de) * | 1990-02-22 | 1991-09-05 | Behringwerke Ag | Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung sowie ihre verwendung |
-
1991
- 1991-10-11 DE DE4133791A patent/DE4133791A1/de not_active Ceased
-
1992
- 1992-09-17 EP EP92115878A patent/EP0537489B1/de not_active Expired - Lifetime
- 1992-09-17 ES ES92115878T patent/ES2141095T3/es not_active Expired - Lifetime
- 1992-09-17 DE DE59209776T patent/DE59209776D1/de not_active Expired - Lifetime
- 1992-09-17 AT AT92115878T patent/ATE187463T1/de active
- 1992-10-08 FI FI924543A patent/FI924543A/fi unknown
- 1992-10-08 NZ NZ244661A patent/NZ244661A/en unknown
- 1992-10-09 CA CA002080260A patent/CA2080260C/en not_active Expired - Fee Related
- 1992-10-09 ZA ZA927785A patent/ZA927785B/xx unknown
- 1992-10-09 JP JP29657492A patent/JP3996649B2/ja not_active Expired - Fee Related
- 1992-10-09 AU AU26298/92A patent/AU670247B2/en not_active Ceased
-
1995
- 1995-06-06 US US08/471,771 patent/US5837824A/en not_active Expired - Lifetime
- 1995-06-06 US US08/468,661 patent/US5639621A/en not_active Expired - Lifetime
- 1995-06-06 US US08/466,272 patent/US5674994A/en not_active Expired - Lifetime
- 1995-06-07 US US08/478,857 patent/US5695758A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2080260C (en) | 2002-12-17 |
JP3996649B2 (ja) | 2007-10-24 |
AU2629892A (en) | 1993-04-22 |
DE4133791A1 (de) | 1993-04-15 |
EP0537489B1 (de) | 1999-12-08 |
US5695758A (en) | 1997-12-09 |
FI924543A (fi) | 1993-04-12 |
US5674994A (en) | 1997-10-07 |
US5639621A (en) | 1997-06-17 |
EP0537489A1 (de) | 1993-04-21 |
NZ244661A (en) | 1995-10-26 |
AU670247B2 (en) | 1996-07-11 |
JPH05317088A (ja) | 1993-12-03 |
FI924543A0 (fi) | 1992-10-08 |
ATE187463T1 (de) | 1999-12-15 |
CA2080260A1 (en) | 1993-04-12 |
ZA927785B (en) | 1994-04-11 |
US5837824A (en) | 1998-11-17 |
DE59209776D1 (de) | 2000-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053440T3 (es) | Anticuerpos monoclonales anti-cancer de mama humano, correspondientes hibridomas, la produccion y utilizacion de los mismos. | |
EP0265500A4 (en) | ANTIBODIES AGAINST HUMAN PROGESTERONE RECEPTOR AND DIAGNOSTIC PRODUCTS AND METHOD. | |
ES516797A0 (es) | Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor. | |
ZA945364B (en) | Antibodies specific for human prostate glandular kallikrein | |
ES8705975A1 (es) | Un metodo de deteccion o localizacion de celulas de carcinoma humano. | |
EP0553244A4 (es) | ||
ES2058083T3 (es) | Anticuerpos monoclonales contra el factor humano de la necrosis tumoral (tnf) y su empleo. | |
NZ210867A (en) | Tumour-specific monoclonal antibodies, production thereof and use | |
MX170804B (es) | Procedimiento mejorado para la hidrogenolisis/deshidrohalogenacion de fluorohalocarburos o fluorohalohidrocarburos | |
ES2141095T3 (es) | Anticuerpos monoclonales contra antigenos asociados a tumores, procedimiento para su preparacion y su uso. | |
NO965395D0 (no) | Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen | |
PT97423A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo conjugados de anticorpos para o tratamento de neoplasias | |
GR3020387T3 (en) | Ctaa 28a32, the antigen recognized by mca 28a32 | |
DK102589A (da) | Antigen, der genkendes af mca 16-88 | |
ES318272A1 (es) | El procedimiento de preparacion de eter 4-bromo-3-clorodifenilico. | |
KR930019820A (ko) | 모노클로날 항-강글리오사이드 항체, 이의 제조방법 및 종양 치료제로서의 용도 | |
BG49665A1 (en) | Hybridom cell line, secreting monoclonal antibody against determinant 05 salmonelli of group b |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 537489 Country of ref document: ES |